Quick Search  in all journalsin this journalin this issue Journals Home Methods and Findings Issues Methods and Findings Policies & Guidelines Subscribe Permissions Contact Us Shopping Cart Purchase History

	Methods and Findings		Register or sign in
	Methods Find Exp Clin Pharmacol 2001, 23(7): 395 ISSN 0379-0355 Copyright 2001 Clarivate Analytics CCC: 0379-0355 DOI: 10.1358/mf.2001.23.7.662127
	Bisphenol A enhances cadmium toxicity through estrogen receptor Sogawa, N., Onodera, K., Sogawa, C.A., Mukubo, Y., Fukoka, H., Oda, N., Furuta, H.
	To clarify the action of estrogenic endocrine disruptors on cadmium (Cd)-induced metallothionein (MT) synthesis in the liver, we investigated the effects of bisphenol A (BPA) on hepatic MT-I mRNA expression and MT contents after Cd injection. Liver damage after Cd injection was assessed by measuring glutamic-pyruvic transaminase (GPT) and glutamic-oxaloacetic transaminase (GOT) activities in the serum. It was found that BPA reduced the Cd-induced expression of MT-I mRNA and MT protein in the liver. The administration of tamoxifen, an estrogen receptor antagonist, prevented the reduction of hepatic MT content by BPA. Moreover, both the GPT and GOT activities of the BPA-treated groups were higher than those of the control groups. These findings suggest that BPA reduced hepatic MT synthesis after Cd injection via the estrogen receptor, which resulted in increased damage to the liver. Full Text: HTML, PDF

	© Clarivate Analytics. All rights reserved.
	Copyright Notice	Terms of Use	Privacy Statement	Cookie Policy